Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Ophthalmology

Listening to the Signs: Symptoms and Health Links

At a Glance

Central Retinal Vein Occlusion (CRVO) typically causes sudden, painless vision loss in one eye. Because it is often linked to systemic conditions like high blood pressure, managing CRVO requires evaluating your overall cardiovascular health and monitoring for emergency complications like neovascular glaucoma.

While the primary symptom of Central Retinal Vein Occlusion (CRVO) is a sudden change in vision, the condition often serves as a “messenger” for the rest of your body. Understanding the warning signs of complications and the underlying health factors that contribute to CRVO can empower you to take charge of your eye health and your overall well-being [1][2].

Common Symptoms and Daily Coping

For most people, CRVO appears as a sudden, painless blurring or loss of vision in one eye [3]. Depending on the severity of the blockage, vision loss may be slight, or it may be quite profound.

While waiting for treatments to take effect, you may notice issues with your depth perception. Activities like pouring coffee, walking down stairs, or reaching for objects can feel disorienting at first. Take things slowly. If you drive, speak with your eye doctor about whether it is currently safe to do so, as driving with only one fully functioning eye requires extra caution and head-turning to check blind spots.

Three Reasons Clots Form

To understand why a vein becomes blocked, doctors look at a concept known in medicine as “Virchow’s Triad”. You don’t need to memorize the Latin jargon; simply put, it describes three main reasons a clot can form [4][5]:

  1. Slow Flow: Blood isn’t moving through the eye’s veins as quickly as it should [6].
  2. Vessel Damage: The “lining” of the blood vessel is damaged, often by long-term high blood pressure or inflammation [6][7].
  3. Sticky Blood: The blood itself is more prone to clotting, which can be caused by certain medications, genetic conditions, or even severe dehydration [6][8].

A “Red Flag” for Systemic Health

CRVO is frequently an early warning sign indicating that your cardiovascular system needs attention [1][2]. Because the tiny veins in the eye are similar to those in the heart and brain, a blockage in the eye can be linked to [9][10]:

  • Hypertension (High Blood Pressure): The most common risk factor for CRVO [11][12].
  • Diabetes: High blood sugar can damage the delicate vessel walls over time [12][13].
  • Clotting Disorders: Especially in younger patients, “sticky blood” conditions like Factor V Leiden or other genetic mutations may be the culprit [14][8].

By addressing these systemic issues now, you may reduce your risk of a future CRVO in the other eye, as well as lower your risk for heart attack or stroke [10][2]. You can also take control of your health by managing lifestyle factors: smoking cessation is highly recommended, as smoking damages blood vessels, and staying well-hydrated helps keep your blood from becoming too concentrated.

Emergency Warning Signs: 90-Day Glaucoma

In some cases, the eye may attempt to grow new, fragile blood vessels to replace the blocked one. This process can lead to a severe complication known as neovascular glaucoma [15][16].

Because this often happens about three months after the initial blockage, it is sometimes called “90-day glaucoma” [17][18]. This causes a dangerous, rapid spike in eye pressure. Watch for these emergency “red flag” symptoms:

  • Severe eye pain or a deep, throbbing ache around the eye [17].
  • Nausea or vomiting accompanying eye pain [17].
  • Extreme redness in the eye [17].
  • A sudden, dramatic drop in vision beyond the initial loss [17].

WHAT TO DO: This is a medical emergency. If you experience these symptoms, do not wait for a scheduled appointment. If it happens during the day, call your ophthalmologist immediately and tell them you need an emergency appointment for severe eye pain. If it happens at night or on the weekend, call the on-call doctor for the clinic. If you cannot reach them, go to the nearest emergency room immediately [15][19].

Common questions in this guide

What are the main symptoms of CRVO?
The most common symptom is a sudden, painless blurring or loss of vision in one eye. You may also experience disorientation or difficulty with depth perception as you adjust to changes in your sight.
Why do blood clots form in the eye veins?
Clots in the eye typically form due to three factors: slow blood flow through the veins, damage to the blood vessel lining from conditions like high blood pressure, or having blood that is more prone to clotting.
What is 90-day glaucoma?
Also known as neovascular glaucoma, this is a severe complication that can happen roughly three months after a vein blockage. It occurs when fragile new blood vessels grow in the eye, causing a dangerous and rapid spike in eye pressure.
What are the emergency warning signs of neovascular glaucoma?
Seek immediate emergency medical care if you experience severe, throbbing eye pain, extreme eye redness, nausea that accompanies eye pain, or a sudden and dramatic drop in your vision.
Is CRVO linked to other health conditions?
A blockage in the eye is often an early warning sign for cardiovascular problems. It is strongly linked to high blood pressure, diabetes, and certain blood clotting disorders like Factor V Leiden.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Did my eye exam show any signs of 'rubeosis' or new blood vessels on my iris?
  2. 2.What is my current eye pressure, and how often should we monitor it to watch for neovascular glaucoma?
  3. 3.What specific blood tests for clotting disorders would you recommend I discuss with my primary doctor?
  4. 4.How soon should I follow up with my primary care physician to evaluate my cardiovascular health?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    CONN SYNDROME PRESENTING AS CENTRAL RETINAL VEIN OCCLUSION.

    Atik A, Wilson D, Essex RW

    Retinal cases & brief reports 2020; (14(1)):20-22 doi:10.1097/ICB.0000000000000611.

    PMID: 28644176
  2. 2

    Retinal Vascular Occlusion and Underlying Generalized Vascular Diseases.

    Feltgen N, Agostini H

    Klinische Monatsblatter fur Augenheilkunde 2023; (240(9)):1071-1076 doi:10.1055/a-2097-0938.

    PMID: 37216967
  3. 3

    IMPACT OF RETINAL ISCHEMIA ON FUNCTIONAL AND ANATOMICAL OUTCOMES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN PATIENTS WITH RETINAL VEIN OCCLUSION.

    Khayat M, Wright DM, Yeong J, et al.

    Retina (Philadelphia, Pa.) 2020; (40(6)):1098-1109 doi:10.1097/IAE.0000000000002571.

    PMID: 31157714
  4. 4

    Acute onset of decreased vision after violently vomiting: A case report.

    He H, Wang Z, Zhou H, Jin ZB

    European journal of ophthalmology 2024; (34(2)):NP87-NP91 doi:10.1177/11206721231208665.

    PMID: 37844619
  5. 5

    Central Retinal Vein Occlusion in Pregnancy: A Rare Case Report.

    Manade VV, Kotecha MR, Sangwan JN, Chodvadiya S

    Annals of African medicine 2026; doi:10.4103/aam.aam_636_25.

    PMID: 41568697
  6. 6

    Retinal vein occlusion following COVID-19 vaccination.

    Peters MC, Cheng SSH, Sharma A, Moloney TP

    Clinical & experimental ophthalmology 2022; (50(4)):459-461 doi:10.1111/ceo.14056.

    PMID: 35113504
  7. 7

    Central retinal vein occlusion associated with platelet activation.

    Citirik M

    Therapeutic advances in ophthalmology 2019; (11()):2515841419864844 doi:10.1177/2515841419864844.

    PMID: 31384723
  8. 8

    CALRETICULIN MUTATION ASSOCIATED WITH BILATERAL CENTRAL RETINAL VEIN OCCLUSION IN A YOUNG WOMAN.

    Kabanovski A, Donaldson L, Koushan K, Margolin E

    Retinal cases & brief reports 2023; (17(4)):389-391 doi:10.1097/ICB.0000000000001200.

    PMID: 34652304
  9. 9

    Cardiovascular risk factors in patients with combined central retinal vein occlusion and cilioretinal artery occlusion: Case report.

    Grzybowski A, Elikowski W, Gaca-Wysocka M

    Medicine 2018; (97(1)):e9255 doi:10.1097/MD.0000000000009255.

    PMID: 29505511
  10. 10

    A review of the management of central retinal artery occlusion.

    Madike R, Cugati S, Chen C

    Taiwan journal of ophthalmology 2022; (12(3)):273-281 doi:10.4103/2211-5056.353126.

    PMID: 36248088
  11. 11

    Current Understanding of Retinal Vein Thrombosis in Older Adults: A Review of the Literature.

    Smekalkina LV, Safonicheva OG, Kabardina EV, et al.

    Clinical interventions in aging 2025; (20()):2399-2407 doi:10.2147/CIA.S548403.

    PMID: 41368277
  12. 12

    Clopidogrel therapy in nonischemic central retinal vein occlusion: A case report and therapeutic insight.

    Al Ghaithi H, Al Hinai A, Al Abri M, Al-Futaisi A

    Oman journal of ophthalmology 2024; (17(3)):380-383 doi:10.4103/ojo.ojo_83_24.

    PMID: 39651499
  13. 13

    Central retinal vein occlusion in young population: risk factors and outcomes.

    Berguig J, Abdelmassih Y, Azar G, et al.

    Frontiers in medicine 2023; (10()):1180234 doi:10.3389/fmed.2023.1180234.

    PMID: 37601780
  14. 14

    Young-Onset Central Retinal Vein Occlusion with Antiphospholipid Syndrome and Hypophysitis.

    Kawata M, Sawamura H, Aoki S, et al.

    Case reports in ophthalmology 2025; (16(1)):693-702 doi:10.1159/000548080.

    PMID: 41063825
  15. 15

    Neovascular glaucoma - A review.

    Senthil S, Dada T, Das T, et al.

    Indian journal of ophthalmology 2021; (69(3)):525-534 doi:10.4103/ijo.IJO_1591_20.

    PMID: 33595466
  16. 16

    The pathological association between the anterior eye segment and the retina in a murine model of neovascular glaucoma.

    Nishinaka A, Tanaka M, Aoshima K, et al.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2022; (36(6)):e22323 doi:10.1096/fj.202101917R.

    PMID: 35485981
  17. 17

    Etiology, pathogenesis, and diagnosis of neovascular glaucoma.

    Călugăru D, Călugăru M

    International journal of ophthalmology 2022; (15(6)):1005-1010 doi:10.18240/ijo.2022.06.20.

    PMID: 35814894
  18. 18

    [Current views on pathogenesis and treatment of neovascular glaucoma].

    Fedoruk NA

    Vestnik oftalmologii 2024; (140(3)):110-116 doi:10.17116/oftalma2024140031110.

    PMID: 38962986
  19. 19

    Expression of platelet-derived growth factor-C in aqueous humor of patients with neovascular glaucoma and its correlation with vascular endothelial growth factor.

    Li Y, Hu D, Lv P, et al.

    European journal of ophthalmology 2020; (30(3)):500-505 doi:10.1177/1120672119832785.

    PMID: 30803266

This page is for informational purposes only and does not replace professional medical advice. Always consult your ophthalmologist or primary care physician regarding sudden vision changes or systemic health concerns.

Get notified when new evidence is published on Central retinal vein occlusion.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.